CJC-1295 No DAC – Aliquot, 5mg
Data Sheet
| Application | Binds to GHRH receptors in the pituitary gland |
| CAS | 446036-97-1 |
| Molar Mass | 3367.9 g/mol |
| Chemical Formula | C152H252N44O42 |
| Amino Acid Sequence | YADAXFXQSYRKVLAQLSARKLLQDXLSR |
| Synonyms | CJC 1295 without DAC, Modified GRF (1-29), DAC:GRF acetate, TS-10609 |
| Storage | Store at ≤4°C, tightly sealed, away from heat, light and moisture. |
| Solubility | Soluble in BAC Water |
| Organoleptic Profile | White powder in 3mL glass aliquot |
| Composition | Each aliquot contains CJC-1295 No DAC |
| Specification | CJC-1295 No DAC content (per aliquot): CJC-1295 No DAC 5mg ±10% |
| Terms | This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering. |
GHRH Analogue Peptide for Growth Hormone and Endocrine Research
CJC-1295 No DAC is a research-grade synthetic peptide widely studied for its potential relevance in growth hormone-releasing hormone (GHRH) signaling, pituitary-endocrine pathway research, pulsatile GH secretion models, and peptide endocrinology investigations. As a shorter-acting GHRH analogue distinct from DAC-modified variants, CJC-1295 No DAC has attracted significant scientific interest in studies involving GH/IGF-associated pathways, growth factor signaling, and metabolic physiology research.
Researchers have investigated CJC-1295 No DAC in models involving GHRH receptor-mediated mechanisms, endocrine signaling pathways, pulsatile secretion regulation, and peptide-mediated metabolic studies. Its investigational profile has made it a notable compound in advanced peptide science.
Supplied as a laboratory-grade aliquot for analytical and research applications.
Common Research Areas
- GHRH Signaling Research
- Growth Hormone Axis Studies
- Pituitary-Endocrine Investigation
- Metabolic and Growth Factor Models
- Peptide Research Applications
How CJC-1295 No DAC Works
CJC-1295 No DAC has been studied for its potential interaction with pathways associated with GHRH receptor signaling, pituitary regulation, and growth factor biology. Researchers have explored its relevance in models involving pulsatile GH-associated mechanisms, endocrine signaling pathways, and peptide-mediated metabolic regulation.
Its modified peptide profile has made it a recurring subject in advanced research science.
Research Overview
CJC-1295 No DAC has been investigated across a range of research models involving endocrine biology, growth factor signaling, and metabolic pathways.
Areas of scientific interest include:
- GHRH pathway studies
- Pituitary signaling investigations
- Growth factor research models
- Metabolic regulation studies
- Peptide pathway research
Its broad research relevance continues to make it a notable compound in peptide science.
CJC-1295 No DAC vs Related Compounds
CJC-1295 No DAC vs CJC-1295 DAC
CJC-1295 No DAC is often researched for pulsatile, shorter-acting GHRH signaling models, while DAC-modified CJC-1295 has drawn interest in extended-duration pathway investigations.
CJC-1295 No DAC vs Tesamorelin
Tesamorelin is commonly investigated as a distinct GHRH analogue, whereas CJC-1295 No DAC is more strongly associated with modified pulsatile signaling research.
Frequently Asked Questions
What is CJC-1295 No DAC studied for?
It is commonly researched in GHRH signaling, growth hormone pathways, pituitary-endocrine regulation, and metabolic-associated models.
What does No DAC mean?
No DAC refers to the non-Drug Affinity Complex form, distinguishing it from longer-acting DAC-modified variants.
How should CJC-1295 No DAC be stored?
Lyophilized peptide aliquots are generally stored refrigerated according to laboratory handling protocols.
